Pfizer Inc. buy Guggenheim
Start price
12.03.25
/
50%
€23.60
Target price
12.03.26
-
Performance (%)
-1.14%
End price
13.03.26
€23.33
Summary
This prediction ended on 13.03.26 with a price of €23.33. With a performance of -1.14%, the BUY prediction for Pfizer Inc. by Guggenheim closed slightly in the red. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -6.576% | -6.576% | 18.788% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten